Fund Insights
Common Fund Bets
See what stocks and ETFs funds are collectively bullish/bearish on
Largest Fund Trades
Explore the largest stock and ETF buys and sells made by funds
High Conviction Trades
Discover high conviction trades that caused a significant change in a fund's stake in a stock
Fund Manager Portfolios
Gain insights from the world’s largest funds and super investors
Analyst Insights
Price Target Consensus
See what stocks research analysts are collectively bullish/bearish on
Latest Ratings Feed
Explore the latest ratings and price targets from the best equity research analysts
Equity Analyst Profiles
Browse analysts, their latest ratings and track record
Research Firm Profiles
Browse research firm recommendations, trends, and performance
WSR Indexes
Fund Manager Index
Stock index based on fund manager consensus updated each quarter
Analyst Index
COMING SOON - Stock index based on equity analyst consensus updated every second
Search
Sign in
Sign up
Ingredion
INGR
Market cap
$7.39B
Overview
Fund Trends
Analyst Outlook
Journalist POV
117.46
USD
+0.32
0.27%
At close
Updated
Feb 27, 4:00 PM EST
Pre-market
After hours
117.46
0.00
0%
1D
5D
1M
3M
6M
YTD
1Y
5Y
10Y
1 day
0.27%
5 days
0.92%
1 month
0.4%
3 months
9.22%
6 months
-9.12%
Year to date
6.99%
1 year
-9.8%
5 years
31.55%
10 years
16.04%
Upgrade to unlock
Positive
Neutral
Negative
Sentiment
3-Months
Positive
Neutral
61.9%
Negative
Positive
Neutral
Negative
Neutral
The Motley Fool
2 hours ago
Ingredion's CEO Sells Nearly 10k Shares for Over $1M
James P. Zallie sold 9,958 shares for a transaction value of ~$1.16 million based on the reported price of $116.55 per share on Feb. 18, 2026. This sale represented 23.2% of Zallie's direct holdings, reducing his direct stake from 42,968 to 33,010 shares.
Neutral
PRNewsWire
5 days ago
Univar Solutions Selected as Ingredion Pharma Solutions Distributor in United States and Canada
Pharmaceutical manufacturers will benefit from deep expertise and an extensive distribution network paired with Ingredion's functional excipients DOWNERS GROVE, Ill., Feb. 24, 2026 /PRNewswire/ -- Univar Solutions LLC ("Univar Solutions" or "the Company"), a leading global solutions provider to users of specialty ingredients and chemicals, today announced that its Ingredients + Specialties from Univar Solutions division has been appointed as a distributor for Ingredion Pharma Solutions, part of Ingredion Incorporated (NYSE: INGR).
Neutral
The Motley Fool
7 days ago
Ingredion's President and CEO Sells 33k Shares Before Becoming New Board Chairman
Ingredion's President and CEO sold 33,597 direct shares for a transaction value of approximately $4.02 million on Feb. 11, 2026. The sale represented 40.11% of Mr.
Neutral
Seeking Alpha
11 days ago
High Dividend Packaged Foods: Relative Favorability
The packaged foods industry has broadly declined over the last year with some producers dropping over 20%; dividend yields have expanded to as much as 9.5%. However, a high dividend yield does might not indicate value, profitability, or financial strength. Twenty-three high yield packaged food producers we compared on a matrix of factors including yield, payout ratio, value, growth, profitability, and debt.
Neutral
Seeking Alpha
11 days ago
Ingredion Incorporated (INGR) Presents at Consumer Analyst Group of New York Conference 2026 Prepared Remarks Transcript
Ingredion Incorporated (INGR) Presents at Consumer Analyst Group of New York Conference 2026 Prepared Remarks Transcript
Neutral
GlobeNewsWire
18 days ago
Ingredion Appoints President and CEO James P. Zallie as Chairman of the Board
WESTCHESTER, Ill., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions, today announced that its board of directors has unanimously elected Jim Zallie, president and CEO, to assume the additional role of chairman of the board, effective immediately.
Positive
Seeking Alpha
21 days ago
Ingredion: Defensive, High-Yield, Undervalued, And Transforming For Growth
Ingredion is reiterated as a Buy, supported by strong financial health and robust free cash flow exceeding guidance. INGR advances strategic pillars—protein and clean label ingredients—while completing its Cost2Compete program, achieving $59M in run-rate savings. 2026 guidance calls for low- to mid-single-digit net sales growth, EPS of $11–$11.80, and free cash flow midpoint of $460M.
Neutral
Seeking Alpha
26 days ago
Ingredion Incorporated (INGR) Q4 2025 Earnings Call Transcript
Ingredion Incorporated (INGR) Q4 2025 Earnings Call Transcript
Positive
Seeking Alpha
26 days ago
Ingredion Q4: Poised For Lackluster First Half, But It Is Getting Interesting
Ingredion Incorporated delivered resilient profitability and has a strong balance sheet despite flat sales and US/Canada production setbacks. INGR guidance for 2024 is cautious: EPS of $11.00-$11.80, low-to-mid single-digit sales growth, and modest operating income improvement. Operational efficiency initiatives and R&D focus on Clean Labels and plant-based ingredients position INGR for future margin expansion.
Negative
Zacks Investment Research
26 days ago
Ingredion (INGR) Misses Q4 Earnings and Revenue Estimates
Ingredion (INGR) came out with quarterly earnings of $2.53 per share, missing the Zacks Consensus Estimate of $2.59 per share. This compares to earnings of $2.63 per share a year ago.
Show more
See News Rankings
Sign up
Sign in
Fund Insights
Common Fund Bets
See what stocks and ETFs funds are collectively bullish/bearish on
Largest Fund Trades
Explore the largest stock and ETF buys and sells made by funds
High Conviction Trades
Discover high conviction trades that caused a significant change in a fund's stake in a stock
Fund Manager Portfolios
Gain insights from the world’s largest funds and super investors
Analyst Insights
Price Target Consensus
See what stocks research analysts are collectively bullish/bearish on
Latest Ratings Feed
Explore the latest ratings and price targets from the best equity research analysts
Equity Analyst Profiles
Browse analysts, their latest ratings and track record
Research Firm Profiles
Browse research firm recommendations, trends, and performance
WSR Indexes
Fund Manager Index
Stock index based on fund manager consensus updated each quarter
Analyst Index
COMING SOON - Stock index based on equity analyst consensus updated every second
Theme
Close